Darrin Beaupre
Chief Tech/Sci/R&D Officer bij IDEAYA BIOSCIENCES, INC.
Profiel
Darrin M.
Beaupre is a Chief Medical Officer at IDEAYA Biosciences, Inc. He previously worked as Head-Early Oncology Development at Pfizer Inc., VP-Clinical Medicine & Early Development at Pharmacyclics LLC, and Chief Medical Officer at Biosplice Therapeutics, Inc. He also worked as an Assistant Professor at Moffit Cancer Center.
Beaupre holds a doctorate degree from The University of Texas Medical School At Houston.
Actieve functies van Darrin Beaupre
| Bedrijven | Functie | Begin |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 21-11-2022 |
Eerdere bekende functies van Darrin Beaupre
| Bedrijven | Functie | Einde |
|---|---|---|
| Moffit Cancer Center | Corporate Officer/Principal | - |
Biosplice Therapeutics, Inc.
 Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | - |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | - |
| PHARMACYCLICS, INC. | Corporate Officer/Principal | - |
Opleiding van Darrin Beaupre
| The University of Texas Medical School At Houston | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| IDEAYA BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Biosplice Therapeutics, Inc.
Biosplice Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Biosplice Therapeutics, Inc. provides medical research and development for tissue-level regeneration. It develops therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. The company was founded by Osman Kibar and John Hood in 2008 and is headquartered in San Diego, CA. | Commercial Services |
| Moffit Cancer Center |
